Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Archive
Authors
About
Podcasts
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Archive
Authors
About
Podcasts
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 10, Issue Suppl 1
LSO-091 Study design of ENERGY: a phase 2/3 trial to assess the efficacy and safety of nipocalimab in warm autoimmune hemolytic anemia
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Short Oral Presentation
Short oral presentation session 16: SLE treatment 2
LSO-091 Study design of ENERGY: a phase 2/3 trial to assess the efficacy and safety of nipocalimab in warm autoimmune hemolytic anemia
Online download statistics by month:
Online download statistics by month: August 2023 to August 2024
Abstract
Full
Pdf
Aug 2023
60
0
10
Sep 2023
39
0
7
Oct 2023
18
0
4
Nov 2023
41
0
7
Dec 2023
48
0
5
Jan 2024
41
0
4
Feb 2024
57
0
10
Mar 2024
111
0
10
Apr 2024
64
0
6
May 2024
78
0
6
Jun 2024
70
0
5
Jul 2024
99
0
7
Aug 2024
63
0
5
Total
789
0
86
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF